147 related articles for article (PubMed ID: 1862083)
1. Reversed siderophores act as antimalarial agents.
Shanzer A; Libman J; Lytton SD; Glickstein H; Cabantchik ZI
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6585-9. PubMed ID: 1862083
[TBL] [Abstract][Full Text] [Related]
2. Mode of action of iron(III) chelators as antimalarials. III. Overadditive effects in the combined action of hydroxamate-based agents on in vitro growth of Plasmodium falciparum.
Tsafack A; Golenser J; Libman J; Shanzer A; Cabantchik ZI
Mol Pharmacol; 1995 Feb; 47(2):403-9. PubMed ID: 7870051
[TBL] [Abstract][Full Text] [Related]
3. The combined effect of iron chelators and classical antimalarials on the in-vitro growth of Plasmodium falciparum.
van Zyl RL; Havlik I; Monteagudo FS
J Antimicrob Chemother; 1992 Sep; 30(3):273-8. PubMed ID: 1452491
[TBL] [Abstract][Full Text] [Related]
4. Mode of action of iron (III) chelators as antimalarials: I. Membrane permeation properties and cytotoxic activity.
Lytton SD; Mester B; Dayan I; Glickstein H; Libman J; Shanzer A; Cabantchik ZI
Blood; 1993 Jan; 81(1):214-21. PubMed ID: 8417790
[TBL] [Abstract][Full Text] [Related]
5. Chemical Determinants of antimalarial activity of reversed siderophores.
Tsafack A; Libman J; Shanzer A; Cabantchik ZI
Antimicrob Agents Chemother; 1996 Sep; 40(9):2160-6. PubMed ID: 8878599
[TBL] [Abstract][Full Text] [Related]
6. Iron chelators: mode of action as antimalarials.
Cabantchik ZI; Glickstein H; Golenser J; Loyevsky M; Tsafack A
Acta Haematol; 1996; 95(1):70-7. PubMed ID: 8604590
[TBL] [Abstract][Full Text] [Related]
7. Antimalarial action of hydroxamate-based iron chelators and potentiation of desferrioxamine action by reversed siderophores.
Golenser J; Tsafack A; Amichai Y; Libman J; Shanzer A; Cabantchik ZI
Antimicrob Agents Chemother; 1995 Jan; 39(1):61-5. PubMed ID: 7695330
[TBL] [Abstract][Full Text] [Related]
8. Iron chelators as antimalarial agents: in vitro activity of dicatecholate against Plasmodium falciparum.
Pradines B; Rolain JM; Ramiandrasoa F; Fusai T; Mosnier J; Rogier C; Daries W; Baret E; Kunesch G; Le Bras J; Parzy D
J Antimicrob Chemother; 2002 Aug; 50(2):177-87. PubMed ID: 12161397
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of iron chelators with masked hydrophilic moieties.
Meijler MM; Arad-Yellin R; Cabantchik ZI; Shanzer A
J Am Chem Soc; 2002 Oct; 124(43):12666-7. PubMed ID: 12392406
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric assessment of hydroxypyridinone iron chelators on in vitro growth of drug-resistant malaria.
Pattanapanyasat K; Thaithong S; Kyle DE; Udomsangpetch R; Yongvanitchit K; Hider RC; Webster HK
Cytometry; 1997 Jan; 27(1):84-91. PubMed ID: 9000589
[TBL] [Abstract][Full Text] [Related]
11. Novel aroylhydrazone and thiosemicarbazone iron chelators with anti-malarial activity against chloroquine-resistant and -sensitive parasites.
Walcourt A; Loyevsky M; Lovejoy DB; Gordeuk VR; Richardson DR
Int J Biochem Cell Biol; 2004 Mar; 36(3):401-7. PubMed ID: 14687919
[TBL] [Abstract][Full Text] [Related]
12. Basic 3-hydroxypyridin-4-ones: potential antimalarial agents.
Dehkordi LS; Liu ZD; Hider RC
Eur J Med Chem; 2008 May; 43(5):1035-47. PubMed ID: 17869385
[TBL] [Abstract][Full Text] [Related]
13. In vitro activities of novel catecholate siderophores against Plasmodium falciparum.
Pradines B; Ramiandrasoa F; Basco LK; Bricard L; Kunesch G; Le Bras J
Antimicrob Agents Chemother; 1996 Sep; 40(9):2094-8. PubMed ID: 8878587
[TBL] [Abstract][Full Text] [Related]
14. Antimalarial properties of orally active iron chelators.
Heppner DG; Hallaway PE; Kontoghiorghes GJ; Eaton JW
Blood; 1988 Jul; 72(1):358-61. PubMed ID: 3291984
[TBL] [Abstract][Full Text] [Related]
15. Effects of hydroxypyridinone iron chelators in combination with antimalarial drugs on the in vitro growth of Plasmodium falciparum.
Pattanapanyasat K; Kotipun K; Yongvanitchit K; Hider RC; Kyle DE; Heppner DG; Walsh DS
Southeast Asian J Trop Med Public Health; 2001 Mar; 32(1):64-9. PubMed ID: 11485097
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibition of Plasmodium falciparum involving carbon centered iron-chelate radical (L., X-)-Fe(III) based on pyridoxal-betaine. A novel type of antimalarials active against chloroquine-resistant parasites.
Iheanacho EN; Sarel S; Samuni A; Avramovici-Grisaru S; Spira DT
Free Radic Res Commun; 1991; 15(1):1-10. PubMed ID: 1663064
[TBL] [Abstract][Full Text] [Related]
17. Antimalarial activity of selected aromatic chelators. IV. Cation uptake by Plasmodium falciparum in the presence of oxines and siderochromes.
Scheibel LW; Stanton GG
Mol Pharmacol; 1986 Oct; 30(4):364-9. PubMed ID: 2945090
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and antimalarial activity of a new class of iron chelators.
Solomon VR; Haq W; Puri SK; Srivastava K; Katti SB
Med Chem; 2006 Mar; 2(2):133-8. PubMed ID: 16787362
[TBL] [Abstract][Full Text] [Related]
19. Differential cytotoxicity of iron chelators on malaria-infected cells versus mammalian cells.
Glickstein H; Breuer W; Loyevsky M; Konijn AM; Shanzer A; Cabantchik ZI
Blood; 1996 Jun; 87(11):4871-8. PubMed ID: 8639861
[TBL] [Abstract][Full Text] [Related]
20. Mode of action of iron (III) chelators as antimalarials: II. Evidence for differential effects on parasite iron-dependent nucleic acid synthesis.
Lytton SD; Mester B; Libman J; Shanzer A; Cabantchik ZI
Blood; 1994 Aug; 84(3):910-5. PubMed ID: 8043872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]